Cervical cancer screening uptake and determinant factors among women in Ambo town, Western Oromia, Ethiopia: Community-based cross-sectional study.

Shewaye F Natae, Digafe T Nigatu, Mulu K Negawo, Wakeshe W Mengesha
Author Information
  1. Shewaye F Natae: Department of Public Health, College of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia. ORCID
  2. Digafe T Nigatu: Department of Public Health, College of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia.
  3. Mulu K Negawo: Department of Nursing, College of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia. ORCID
  4. Wakeshe W Mengesha: Department of Public Health, College of Medicine and Health Sciences, Ambo University, Ambo, Ethiopia.

Abstract

BACKGROUND: cervical cancer is the second most common cancer and the leading cause of cancer-related death in Ethiopian women. About 77.6% of women died of 6294 new cases reported in 2019. Early screening for cervical cancer has substantially reduced morbidity and mortality attributed to it. In Ethiopia, most of the women visit the health facilities at the late stage of the disease in which the offered intervention is not promising. Therefore, we aimed to assess the level of cervical cancer screening uptake and its determinant among women of Ambo town, Ethiopia.
METHODS: Community-based cross-sectional study was conducted among 422 women aged 20-65 years. An interviewer-administered questionnaire was used to collect the data. Data were analyzed using SPSS version 25. Estimates were presented using an odds ratio (OR) with 95% CI. Statistical significance was declared at a p value of <0.05.
RESULTS: In the present study, 392 women were participated giving a response rate of 93%. Only 8.7% (34) of the study participants were received cervical cancer screening in their lifetime. Being in the age group of 30-39 years (AOR = 3.2, 95% CI: 1.22, 8.36), having cervical cancer-related discussions with a healthcare provider (AOR = 3.5; 95% CI: 1.17, 10.7), and knowing the availability of cervical cancer screening service (AOR = 2.8; 95% CI: 1.03, 7.87) were significantly associated with uptake of cervical cancer screening.
CONCLUSION: In this study, cervical cancer screening uptake is very low. Our study identifies clues for determinants of cervical cancer screening uptake. Thus, further studies using a better study design might be helpful to explore determinants of low utilization of CC screening services and suggest an appropriate intervention that increases CC screening uptake in the study area.

Keywords

References

  1. Glob Health Action. 2016 Feb 16;9:29336 [PMID: 26895145]
  2. Ann Surg Oncol. 2015 Mar;22(3):728-33 [PMID: 25605513]
  3. BMC Womens Health. 2017 Jan 31;17(1):9 [PMID: 28137260]
  4. BMJ Open. 2019 Mar 13;9(3):e026413 [PMID: 30872552]
  5. BMC Womens Health. 2020 Jul 16;20(1):147 [PMID: 32677933]
  6. Lancet Glob Health. 2020 Feb;8(2):e191-e203 [PMID: 31812369]
  7. Vaccine. 2013 Dec 29;31 Suppl 5:F32-46 [PMID: 24331746]
  8. PLoS One. 2013 Dec 20;8(12):e84519 [PMID: 24376818]
  9. Int J Health Sci (Qassim). 2016 Jan;10(1):137-43 [PMID: 27004064]
  10. Curr Probl Cancer. 2018 Sep;42(5):457-465 [PMID: 30064936]
  11. BMC Public Health. 2019 Aug 14;19(1):1102 [PMID: 31412831]
  12. Expert Rev Anti Infect Ther. 2017 Jun;15(6):613-627 [PMID: 28440679]
  13. BMC Cancer. 2020 Jun 17;20(1):563 [PMID: 32552740]
  14. PLoS One. 2016 Mar 10;11(3):e0149908 [PMID: 26963098]
  15. JAMA. 2018 Jul 3;320(1):43-52 [PMID: 29971397]
  16. BMC Res Notes. 2019 Aug 19;12(1):520 [PMID: 31426848]
  17. PLoS One. 2020 Apr 7;15(4):e0231307 [PMID: 32255807]
  18. BMC Cancer. 2013 Jan 02;13:2 [PMID: 23282173]
  19. Afr Health Sci. 2018 Sep;18(3):623-636 [PMID: 30602995]
  20. Ethiop J Health Sci. 2015 Oct;25(4):345-52 [PMID: 26949299]
  21. Br J Cancer. 2016 Oct 25;115(9):1140-1146 [PMID: 27632376]
  22. J Nat Sci Biol Med. 2015 Jul-Dec;6(2):324-8 [PMID: 26283822]
  23. PLoS One. 2018 Jan 19;13(1):e0191506 [PMID: 29352278]
  24. BMC Womens Health. 2019 Dec 16;19(1):162 [PMID: 31842845]
  25. Cancer Prev Res (Phila). 2020 Jul;13(7):593-600 [PMID: 32371553]
  26. BMC Cancer. 2018 Mar 16;18(1):298 [PMID: 29548313]
  27. Curr Opin Obstet Gynecol. 2016 Feb;28(1):4-10 [PMID: 26642063]
  28. Lancet. 2019 Jan 12;393(10167):169-182 [PMID: 30638582]
  29. Int J Cancer. 2010 Dec 15;127(12):2893-917 [PMID: 21351269]
  30. Vaccine. 2013 Dec 29;31 Suppl 5:F1-31 [PMID: 24331745]
  31. Lancet. 2013 Sep 7;382(9895):889-99 [PMID: 23618600]
  32. PLoS One. 2017 Jul 25;12(7):e0181415 [PMID: 28742851]
  33. Eur J Cancer Care (Engl). 2017 Jan;26(1): [PMID: 26853214]
  34. J Womens Health (Larchmt). 2019 Aug;28(8):1094-1104 [PMID: 30874477]
  35. Ethiop Med J. 2015 Apr;53(2):65-74 [PMID: 26591294]
  36. Lancet. 2007 Aug 4;370(9585):398-406 [PMID: 17679017]
  37. BMJ Open. 2017 Jun 11;7(6):e016282 [PMID: 28606908]
  38. Int J Equity Health. 2012 Dec 29;11:83 [PMID: 23273140]
  39. JAMA Oncol. 2017 Apr 1;3(4):524-548 [PMID: 27918777]
  40. Cancer Med. 2021 Dec;10(23):8651-8661 [PMID: 34704666]
  41. Heliyon. 2021 May 17;7(5):e07051 [PMID: 34041397]
  42. Lancet. 2014 Feb 8;383(9916):524-32 [PMID: 24192252]
  43. Trop Med Int Health. 2010 Aug;15(8):890-3 [PMID: 20545913]
  44. Climacteric. 2018 Jun;21(3):235-238 [PMID: 29488817]
  45. PLoS One. 2019 Mar 14;14(3):e0213546 [PMID: 30870497]
  46. Ann Glob Health. 2014 Sep-Oct;80(5):412-7 [PMID: 25512156]
  47. CA Cancer J Clin. 2018 Nov;68(6):394-424 [PMID: 30207593]
  48. Cancer Manag Res. 2020 Sep 16;12:8519-8526 [PMID: 32982444]
  49. J Cancer Educ. 2017 Dec;32(4):901-907 [PMID: 27075197]
  50. Eur J Public Health. 2018 Dec 1;28(6):1156-1162 [PMID: 30346504]
  51. JAMA. 2018 Aug 21;320(7):674-686 [PMID: 30140884]
  52. Infect Agent Cancer. 2014 Oct 08;9(1):33 [PMID: 25320636]

MeSH Term

Adult
Aged
Cross-Sectional Studies
Early Detection of Cancer
Ethiopia
Female
Humans
Middle Aged
Uterine Cervical Neoplasms

Word Cloud

Created with Highcharts 10.0.0cancerscreeningcervicalstudywomenuptake95%Ethiopiaamongusing8CI:1Cervicalcancer-relatedinterventiondeterminantAmbotownCommunity-basedcross-sectionalAOR = 37lowdeterminantsCCBACKGROUND:secondcommonleadingcausedeathEthiopian776%died6294newcasesreported2019EarlysubstantiallyreducedmorbiditymortalityattributedvisithealthfacilitieslatestagediseaseofferedpromisingThereforeaimedassesslevelMETHODS:conducted422aged20-65 yearsinterviewer-administeredquestionnaireusedcollectdataDataanalyzedSPSSversion25EstimatespresentedoddsratioORCIStatisticalsignificancedeclaredp value<005RESULTS:present392participatedgivingresponserate93%7%34participantsreceivedlifetimeagegroup30-39 years22236discussionshealthcareprovider51710knowingavailabilityserviceAOR = 20387significantlyassociatedCONCLUSION:identifiescluesThusstudiesbetterdesignmighthelpfulexploreutilizationservicessuggestappropriateincreasesareafactorsWesternOromiaEthiopia:developingcountriesearlydetectionuterineneoplasms

Similar Articles

Cited By